Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 bioavailability and food-effect study of SAR443122 in healthy adults
NL-OMON60139Phase 1Completed
- Sponsor
- Sanofi
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of eclitasertib in autoimmune colitis, sponsored by Sanofi. Primary endpoint: Primary endpoint(s). Started Jun 2025; status: completed.
02
Drugs
eclitasertib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON60139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60139.